Literature DB >> 20823215

Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes.

Christopher W Kaplan1, Xiaoyuan Ma, Avina Paranjpe, Anahid Jewett, Renate Lux, Susan Kinder-Haake, Wenyuan Shi.   

Abstract

Bacterially induced cell death in human lymphocytes is an important virulence factor for pathogenic bacteria. Previously discovered mechanisms of bacterially induced cell death are predominantly based on the transfer of bacterial proteins to the target host cell, such as the toxins secreted through type I, II, and VI secretion systems or effector proteins injected through type III, IV, and Vb secretion systems. Here, we report a mechanism employed by the Gram-negative oral pathogen Fusobacterium nucleatum for cell death induction of human lymphocytes via two outer membrane proteins (OMPs), Fap2 and RadD, which share regions homologous to autotransporter secretion systems (type Va secretion systems). Genetic and physiological studies established that inactivation of the two OMPs led to significantly reduced ability to trigger cell death in Jurkat cells, while the corresponding double mutant was almost completely attenuated. Additional biochemical and molecular analyses demonstrated that cell-free F. nucleatum membranes are sufficient to induce cell death in Jurkat cells, suggesting that no active process or effector protein transfer was necessary to induce eukaryotic cell death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20823215      PMCID: PMC2976331          DOI: 10.1128/IAI.00567-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  Hijacking of apoptotic pathwaysby bacterial pathogens.

Authors:  L Gao; Y Abu Kwaik
Journal:  Microbes Infect       Date:  2000-11       Impact factor: 2.700

2.  Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS.

Authors:  D Kuck; B Kolmerer; C Iking-Konert; P H Krammer; W Stremmel; J Rudi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586.

Authors:  Vinayak Kapatral; Iain Anderson; Natalia Ivanova; Gary Reznik; Tamara Los; Athanasios Lykidis; Anamitra Bhattacharyya; Allen Bartman; Warren Gardner; Galina Grechkin; Lihua Zhu; Olga Vasieva; Lien Chu; Yakov Kogan; Oleg Chaga; Eugene Goltsman; Axel Bernal; Niels Larsen; Mark D'Souza; Theresa Walunas; Gordon Pusch; Robert Haselkorn; Michael Fonstein; Nikos Kyrpides; Ross Overbeek
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

4.  Haemolysin contributes to virulence of extra-intestinal E. coli infections.

Authors:  R A Welch; E P Dellinger; B Minshew; S Falkow
Journal:  Nature       Date:  1981-12-17       Impact factor: 49.962

5.  Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin.

Authors:  Timothy L Cover; Uma S Krishna; Dawn A Israel; Richard M Peek
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

6.  Suppression of human peripheral blood lymphocytes by Fusobacterium nucleatum.

Authors:  B J Shenker; J M DiRienzo
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Bacteriology of severe periodontitis in young adult humans.

Authors:  W E Moore; L V Holdeman; R M Smibert; D E Hash; J A Burmeister; R R Ranney
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Bacteriology of experimental gingivitis in young adult humans.

Authors:  W E Moore; L V Holdeman; R M Smibert; I J Good; J A Burmeister; K G Palcanis; R R Ranney
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Monocyte suppression of Fusobacterium nucleatum-induced human polyclonal B-lymphocyte activation.

Authors:  D F Mangan; T Won; D E Lopatin
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Genome analysis of F. nucleatum sub spp vincentii and its comparison with the genome of F. nucleatum ATCC 25586.

Authors:  Vinayak Kapatral; Natalia Ivanova; Iain Anderson; Gary Reznik; Anamitra Bhattacharyya; Warren L Gardner; Natalia Mikhailova; Alla Lapidus; Niels Larsen; Mark D'Souza; Theresa Walunas; Robert Haselkorn; Ross Overbeek; Nikos Kyrpides
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

View more
  64 in total

Review 1.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

2.  Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatum.

Authors:  T Wu; L Cen; C Kaplan; X Zhou; R Lux; W Shi; X He
Journal:  J Dent Res       Date:  2015-07-07       Impact factor: 6.116

3.  Pathogenic bacterial species associated with endodontic infection evade innate immune control by disabling neutrophils.

Authors:  Aritsune Matsui; Jun-O Jin; Christopher D Johnston; Hajime Yamazaki; Yael Houri-Haddad; Susan R Rittling
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

Review 4.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

5.  Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth.

Authors:  S Coppenhagen-Glazer; A Sol; J Abed; R Naor; X Zhang; Y W Han; G Bachrach
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

6.  Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

Authors:  Kosuke Mima; Yasutaka Sukawa; Reiko Nishihara; Zhi Rong Qian; Mai Yamauchi; Kentaro Inamura; Sun A Kim; Atsuhiro Masuda; Jonathan A Nowak; Katsuhiko Nosho; Aleksandar D Kostic; Marios Giannakis; Hideo Watanabe; Susan Bullman; Danny A Milner; Curtis C Harris; Edward Giovannucci; Levi A Garraway; Gordon J Freeman; Glenn Dranoff; Andrew T Chan; Wendy S Garrett; Curtis Huttenhower; Charles S Fuchs; Shuji Ogino
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

7.  Adherence to streptococci facilitates Fusobacterium nucleatum integration into an oral microbial community.

Authors:  Xuesong He; Wei Hu; Christopher W Kaplan; Lihong Guo; Wenyuan Shi; Renate Lux
Journal:  Microb Ecol       Date:  2011-12-28       Impact factor: 4.552

Review 8.  The colorectal cancer immune microenvironment and approach to immunotherapies.

Authors:  Minoru Koi; John M Carethers
Journal:  Future Oncol       Date:  2017-08-22       Impact factor: 3.404

9.  Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke.

Authors:  H Nishi; N Hosomi; K Ohta; S Aoki; M Nakamori; T Nezu; H Shigeishi; T Shintani; T Obayashi; K Ishikawa; N Kinoshita; Y Shiga; M Sugiyama; H Ohge; H Maruyama; H Kawaguchi; H Kurihara
Journal:  Clin Exp Immunol       Date:  2020-03-24       Impact factor: 4.330

10.  Discovery and characterization of de novo sialic acid biosynthesis in the phylum Fusobacterium.

Authors:  Amanda L Lewis; Lloyd S Robinson; Kavita Agarwal; Warren G Lewis
Journal:  Glycobiology       Date:  2016-09-09       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.